
Deepa Belur
Examiner (ID: 2176, Phone: (571)270-3722 , Office: P/2472 )
| Most Active Art Unit | 2472 |
| Art Unit(s) | 2472 |
| Total Applications | 650 |
| Issued Applications | 513 |
| Pending Applications | 62 |
| Abandoned Applications | 96 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17035216
[patent_doc_number] => 20210252174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => METHOD
[patent_app_type] => utility
[patent_app_number] => 17/125531
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125531
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125531 | METHOD | Dec 16, 2020 | Abandoned |
Array
(
[id] => 17005502
[patent_doc_number] => 20210236663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/125905
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125905 | Compounds and probes for imaging huntingtin protein | Dec 16, 2020 | Issued |
Array
(
[id] => 19210662
[patent_doc_number] => 11999710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Radiolabeled cannabinoid receptor 2 ligand
[patent_app_type] => utility
[patent_app_number] => 17/125655
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8209
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/125655 | Radiolabeled cannabinoid receptor 2 ligand | Dec 16, 2020 | Issued |
Array
(
[id] => 20315247
[patent_doc_number] => 12453786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Radiomics-based treatment decision support for lung cancer
[patent_app_type] => utility
[patent_app_number] => 17/757017
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 96
[patent_no_of_words] => 25371
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/757017 | Radiomics-based treatment decision support for lung cancer | Dec 6, 2020 | Issued |
Array
(
[id] => 16720002
[patent_doc_number] => 20210087149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => NEUROTENSIN RECEPTOR LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/112258
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112258
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112258 | NEUROTENSIN RECEPTOR LIGANDS | Dec 3, 2020 | Abandoned |
Array
(
[id] => 20730151
[patent_doc_number] => 12637398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Radiohalogen prosthetic moieties and radiolabeled biomolecules
[patent_app_type] => utility
[patent_app_number] => 17/776330
[patent_app_country] => US
[patent_app_date] => 2020-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3853
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776330 | Radiohalogen prosthetic moieties and radiolabeled biomolecules | Nov 10, 2020 | Issued |
Array
(
[id] => 18164979
[patent_doc_number] => 20230031576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => RADIOLABELLED TARGETING LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/775150
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17775150
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/775150 | RADIOLABELLED TARGETING LIGANDS | Nov 5, 2020 | Abandoned |
Array
(
[id] => 16749896
[patent_doc_number] => 20210101905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => Development of Imaging and Therapeutic Glucose Analogues for Sodium Dependent Glucose Transporters
[patent_app_type] => utility
[patent_app_number] => 17/062018
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062018 | Development of Imaging and Therapeutic Glucose Analogues for Sodium Dependent Glucose Transporters | Oct 1, 2020 | Abandoned |
Array
(
[id] => 16726591
[patent_doc_number] => 20210093738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => RADIOLABELLED MGL PET LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/036919
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/036919 | Radiolabelled MGL pet ligands | Sep 28, 2020 | Issued |
Array
(
[id] => 16710492
[patent_doc_number] => 20210077639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => RADIOPHARMACEUTICAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/026571
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/026571 | RADIOPHARMACEUTICAL PRODUCTS | Sep 20, 2020 | Abandoned |
Array
(
[id] => 17981287
[patent_doc_number] => 20220347323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Positron Emission Tomography Guided Delivery of Mitochondral Complex I Inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/760846
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760846
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760846 | Positron Emission Tomography Guided Delivery of Mitochondral Complex I Inhibitors | Sep 17, 2020 | Pending |
Array
(
[id] => 18732595
[patent_doc_number] => 11801315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Radioligands for myelin
[patent_app_type] => utility
[patent_app_number] => 17/014803
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 26
[patent_no_of_words] => 25411
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014803 | Radioligands for myelin | Sep 7, 2020 | Issued |
Array
(
[id] => 18084387
[patent_doc_number] => 11534494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Formulation and method of synthesis
[patent_app_type] => utility
[patent_app_number] => 16/997188
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7012
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997188
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997188 | Formulation and method of synthesis | Aug 18, 2020 | Issued |
Array
(
[id] => 16627543
[patent_doc_number] => 20210046196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => FLUORINATED BETA-HYDROXYBUTYRIC ACIDS FOR PET IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/992940
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992940 | Fluorinated beta-hydroxybutyric acids for PET imaging | Aug 12, 2020 | Issued |
Array
(
[id] => 18753849
[patent_doc_number] => 20230357154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => BUTYRYLCHOLINESTERASE COMPOUNDS AND USE IN DISEASES OF THE NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/592942
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592942
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592942 | BUTYRYLCHOLINESTERASE COMPOUNDS AND USE IN DISEASES OF THE NERVOUS SYSTEM | Aug 6, 2020 | Pending |
Array
(
[id] => 17836524
[patent_doc_number] => 20220273829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/631600
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631600 | RADIOLABELED SUGARS FOR IMAGING OF FUNGAL INFECTIONS | Jul 30, 2020 | Pending |
Array
(
[id] => 16582731
[patent_doc_number] => 20210017133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => USE OF FLUORINATED DERIVATIVES OF 4-AMINOPYRIDINE IN THERAPEUTICS AND MEDICAL IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/947395
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16947395
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/947395 | USE OF FLUORINATED DERIVATIVES OF 4-AMINOPYRIDINE IN THERAPEUTICS AND MEDICAL IMAGING | Jul 29, 2020 | Abandoned |
Array
(
[id] => 16420673
[patent_doc_number] => 20200345871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => RADIOLABELLED OLIGONUCLEOTIDES AND PROCESS FOR THEIR PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/936980
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936980 | RADIOLABELLED OLIGONUCLEOTIDES AND PROCESS FOR THEIR PREPARATION | Jul 22, 2020 | Abandoned |
Array
(
[id] => 16420672
[patent_doc_number] => 20200345870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/929803
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929803 | POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR | Jul 14, 2020 | Abandoned |
Array
(
[id] => 16451117
[patent_doc_number] => 20200360543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 16/915724
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16915724
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/915724 | RADIOTRACERS FOR IMAGING ER-POSITIVE BREAST CANCER | Jun 28, 2020 | Abandoned |